マウスのJunDは,線維芽細胞の成長を否定的に調節し,rasによって変換を逆らいます
Cell
|February 25, 1994
まとめ
静止細胞におけるJunDタンパク質の蓄積と,刺激時にその急速な分解は,c-Junダイナミクスと対照的です. これらの転写因子であるJunDとc-Junは,細胞サイクル進行とras媒介による変異において対極的な役割を果たしている.
科学分野:
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
- がん研究 がん研究
背景:
- c-JunとJunDは,細胞プロセスに関与する関連する転写因子です.
- NIH 3T3線維芽細胞の静止状態および増殖におけるそれらの役割は完全に理解されていません.
研究 の 目的:
- 線維芽細胞の細胞周期調節におけるc-JunとJunDタンパク質の異なる役割を調査する.
- 細胞変換におけるc-JunとJunDの対極的な機能を決定する.
主な方法:
- 静止状態と血清刺激中のc-JunとJunDタンパク質濃度の分析.
- NIH 3T3線維芽細胞におけるJunDとc-Junの過剰発現に関する研究.
- 細胞サイクル分布の評価 (G0/G1,S,G2,Mフェーズ).
- JunDおよびc-Jun共表現によるラス媒介細胞変容の評価.
主要な成果:
- c-Junタンパク質は,NIH 3T3線維芽細胞が静止状態に入ると減少し,JunDタンパク質は蓄積する.
- 休息している細胞の刺激により,核のJunDが急速に分解され,c-JunとJunDの再合成が続く.
- JunD過剰発現は細胞成長を遅らせ,G0/G1相群を増やす.
- c-Junの過剰発現は,より大きなS/G2およびM段階の集団を促進します.
- JunDはras媒介の変換を抑制し,c-Junはrasと協力して細胞を変換する.
結論:
- c-JunとJunDのタンパク質は,線維芽細胞の細胞サイクル進行を調節する上で,対極的な機能を示す.
- これらの転写因子は,細胞変容において対照的な役割を果たし,JunDは抑制剤として,c-Junは促進剤として作用する.
- c-JunとJunDの微分調節と機能は,細胞行動における複雑な相互作用を強調しています.
関連する概念動画
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...